Related Experiment Video
Updated: Aug 9, 2026

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
Published on: March 30, 2018
The Epstein-Barr virus LMP1 interactome: biological implications and therapeutic targets
Mujeeb R Cheerathodi1, David G Meckes1
1Department of Biomedical Sciences, Florida State University College of Medicine, Tallahassee, FL, 32306.
Abstract:
The oncogenic potential of Epstein-Barr virus (EBV) is mostly attributed to latent membrane protein 1 (LMP1), which is essential and sufficient for transformation of fibroblast and primary lymphocytes. LMP1 expression results in the activation of multiple signaling cascades like NF-ΚB and MAP kinases that trigger cell survival and proliferative pathways. LMP1 specific signaling events are mediated through the recruitment of a number of interacting proteins to various signaling domains. Based on these properties, LMP1 is an attractive target to develop effective therapeutics to treat EBV-related malignancies. In this review, we focus on LMP1 interacting proteins, associated signaling events, and potential targets that could be exploited for therapeutic strategies.
Related Concept Videos
Non-LTR Retrotransposons
Human Virome
Inhibitors of Viral Protein Synthesis
Inhibitors of Virion Maturation and Assembly

